TY - JOUR
T1 - Heart organoids and tissue models for modeling development and disease
AU - Miyamoto, Matthew
AU - Nam, Lucy
AU - Kannan, Suraj
AU - Kwon, Chulan
N1 - Funding Information:
We thank Dr. Giuliana Rossi and Dr. Michael Miyamoto for providing insightful comments and feedback in preparing this manuscript. This work was supported by grants from National Institutes of Health, USA ( 1R01HD086026 ), American Heart Association, USA ( 18EIA33890038 , 20PRE35200028 ), Maryland Stem Cell Research Fund ( 2019-MSCRFD-5044 ), Department of Defense ( W81XWH-20-1-0078 ) and Saving tiny Hearts Society, USA .
Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2021/10
Y1 - 2021/10
N2 - Organoids, or miniaturized organs formed in vitro, hold potential to revolutionize how researchers approach and answer fundamental biological and pathological questions. In the context of cardiac biology, development of a bona fide cardiac organoid enables study of heart development, function, and pathogenesis in a dish, providing insight into the nature of congenital heart disease and offering the opportunity for high-throughput probing of adult heart disease and drug discovery. Recently, multiple groups have reported novel methods for generating in vitro models of the heart; however, there are substantial conceptual and methodological differences. In this review we will evaluate recent cardiac organoid studies through the lens of the core principles of organoid technology: patterned self-organization of multiple cell types resembling the in vivo organ. Based on this, we will classify systems into the following related types of tissues: developmental cardiac organoids, chamber cardiac organoids, microtissues, and engineered heart tissues. Furthermore, we highlight the interventions which allow for organoid formation, such as modulation of highly conserved cardiogenic signaling pathways mediated by developmental morphogens. We expect that consolidation and categorization of existing organoid models will help eliminate confusion in the field and facilitate progress towards creation of an ideal cardiac organoid.
AB - Organoids, or miniaturized organs formed in vitro, hold potential to revolutionize how researchers approach and answer fundamental biological and pathological questions. In the context of cardiac biology, development of a bona fide cardiac organoid enables study of heart development, function, and pathogenesis in a dish, providing insight into the nature of congenital heart disease and offering the opportunity for high-throughput probing of adult heart disease and drug discovery. Recently, multiple groups have reported novel methods for generating in vitro models of the heart; however, there are substantial conceptual and methodological differences. In this review we will evaluate recent cardiac organoid studies through the lens of the core principles of organoid technology: patterned self-organization of multiple cell types resembling the in vivo organ. Based on this, we will classify systems into the following related types of tissues: developmental cardiac organoids, chamber cardiac organoids, microtissues, and engineered heart tissues. Furthermore, we highlight the interventions which allow for organoid formation, such as modulation of highly conserved cardiogenic signaling pathways mediated by developmental morphogens. We expect that consolidation and categorization of existing organoid models will help eliminate confusion in the field and facilitate progress towards creation of an ideal cardiac organoid.
KW - Cardiac organoid
KW - Engineered heart tissue
KW - Gastruloid
KW - Self-organization
UR - http://www.scopus.com/inward/record.url?scp=85103249407&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103249407&partnerID=8YFLogxK
U2 - 10.1016/j.semcdb.2021.03.011
DO - 10.1016/j.semcdb.2021.03.011
M3 - Review article
C2 - 33775518
AN - SCOPUS:85103249407
SN - 1084-9521
VL - 118
SP - 119
EP - 128
JO - Seminars in Cell and Developmental Biology
JF - Seminars in Cell and Developmental Biology
ER -